Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALT2: Tolvaptan in Patients With Hyponatremia
NCT00201994Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2003
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in hyponatremia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Nov 2003; status: completed.
02
Drugs
tolvaptan
03
Conditions
hyponatremia
Beyond the preview
Go deeper on NCT00201994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201994.